The overall aim of the Core - 9002 (Systems Neuroscience) is to provide the instrumental base for the neurobiological components of the individual projects and to develop novel methods. The use of different Alzheimer~s disease (AD)-related animal models and the development and testing of numerous treatment strategies in different species (multimodel approach) is the major focus of this core. Aged, cognitively impaired rats, rats with transections of the fimbria-fornic or the perforant pathway, and mice with specific gene defects for nerve growth factor (NGF), choline acetyltransferase (ChAT) and glutam ate receptor-2 (GluR-2) will function as experimental tools for testing different ex vivo and in vivo gene transfer interventions. 9002 will provide standardized surgical (lesioning techniques, ex vivo and in vivo gene transfer), behavioral (sensorimotor function, general activity, acoustic startle, passive avoidance, water maze, five-choice serial visual discrimination, spatial delayed nonmatch-to-sample), biochemical (ChAT activity, acetylcholine, monoamines and their metobolies, amino acids) and morphological (histochemistry, immunohistochemistry, immunofluorenscence, in situ hybridization, stereology, electron microscopy) methods. This multimethodical approach supports the individual projects and, by standardizing the various methods in multiple AD-related animal models, it will enable this program to make direct comparisons between results from each project. Finally, this standardized multimodel and multimethodical strategy will help to identify potential treatments in age-dependent cognitive dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG010435-09
Application #
6098379
Study Section
Project Start
1999-03-01
Project End
2000-02-29
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Nagahara, Alan H; Wilson, Bayard R; Ivasyk, Iryna et al. (2018) MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates. Gene Ther 25:104-114
Chen, Zhijiang; Donnelly, Christopher R; Dominguez, Bertha et al. (2017) p75 Is Required for the Establishment of Postnatal Sensory Neuron Diversity by Potentiating Ret Signaling. Cell Rep 21:707-720
Hirai, Maretoshi; Arita, Yoh; McGlade, C Jane et al. (2017) Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation. J Clin Invest 127:569-582
Overk, Cassia; Masliah, Eliezer (2017) Perspective on the calcium dyshomeostasis hypothesis in the pathogenesis of selective neuronal degeneration in animal models of Alzheimer's disease. Alzheimers Dement 13:183-185
Wang, Ling; Conner, James M; Nagahara, Alan H et al. (2016) Rehabilitation drives enhancement of neuronal structure in functionally relevant neuronal subsets. Proc Natl Acad Sci U S A 113:2750-5
Valera, Elvira; Masliah, Eliezer (2016) Combination therapies: The next logical Step for the treatment of synucleinopathies? Mov Disord 31:225-34
Kratter, Ian H; Zahed, Hengameh; Lau, Alice et al. (2016) Serine 421 regulates mutant huntingtin toxicity and clearance in mice. J Clin Invest 126:3585-97
van den Hurk, Mark; Kenis, Gunter; Bardy, Cedric et al. (2016) Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency. Epigenomics 8:1131-49
Biane, Jeremy S; Takashima, Yoshio; Scanziani, Massimo et al. (2016) Thalamocortical Projections onto Behaviorally Relevant Neurons Exhibit Plasticity during Adult Motor Learning. Neuron 89:1173-1179
Spencer, Brian; Desplats, Paula A; Overk, Cassia R et al. (2016) Reducing Endogenous ?-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model. J Neurosci 36:7971-84

Showing the most recent 10 out of 183 publications